1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Notice of Special Interest (NOSI): Quantum Sensing Technologies in Biomedical Applications is sponsored by National Institutes of Health (NIH) - National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Eye Institute (NEI), National Heart, Lung, and Blood Institute (NHLBI), National Institute of General Medical Sciences (NIGMS), National Center for Advancing Translational Sciences (NCATS), National Cancer Institute (NCI).
This NOSI supports innovative research projects in quantum technology applications in biomedical disciplines, focusing on quantum sensing to improve sensing performance and enhance biological imaging and sensing measurements. The goal is to advance biomedical research and clinical translation through novel sensing technologies.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Multiple NIH institutes and centers are participating. Applicants should apply through an appropriate NIH Parent Funding Announcement or another broad NIH opportunity. Confirm the full requirements in the official notice before applying.
Notice of Special Interest (NOSI): Quantum Sensing Technologies in Biomedical Applications is funded by National Institutes of Health (NIH) - National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Eye Institute (NEI), National Heart, Lung, and Blood Institute (NHLBI), National Institute of General Medical Sciences (NIGMS), National Center for Advancing Translational Sciences (NCATS), National Cancer Institute (NCI). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Five NHLBI Catalyze Product Definition RFAs — HL-26-016 through HL-26-020 — carry an October 21, 2026 receipt date, budget caps of $300,000 to $400,000 per year, and roughly 8 new awards annually. The science is not the gate. An Accelerator Partner and a 0.25:1 non-federal cost match are, and both take longer to line up than the nine weeks you have left.
Read articlePAR-27-056 replaces the long-running IDeA-CTR U54 cooperative agreement with a P30 center core grant and splits the program into Development and Network tracks. Posted August 19, 2026, with a first estimated due date of October 9. Here is what the mechanism swap actually changes for the 23 IDeA states and Puerto Rico.
Read articleThe NIH Common Fund launched PRIMED-AI — Precision Medicine with AI: Integrating Imaging with Multimodal Data — as five coordinated funding opportunities (RFA-RM-27-011 through -015) that build a full pipeline from standards to clinic. Here is how the Playbook, Data-to-Model partnerships, Model-to-Clinic translation, Validation Center, and Logistics Center fit together, what each pays, who is eligible, and how to position before the October 2026 deadlines.
Read article